Background:
In most branches of medicine patent expirations and the use of generic regimens has become standard practice, however as the current US HIV treatment guidelines lack sufficient data to make evidence-based recommendations, the role of generics for treatment of HIV in the US is still unclear.
The Forum and its partners, HIVMA and ACRIA, plan to organize a one- or two-day roundtable to identify and discuss issues that will or may need to be addressed as generic ARVs continue to become available. Using its unique approach, the Forum can bring together key stakeholders from academia, community groups, clinicians, industry, and government to address the myriad questions and issues
Materials and Links:
Presentations
- Jeremy Greene, Johns Hopkins Medical Institute
- Jay Thomas, Georgetown Law Center
- Xiaofei (Sophie) Wang, FDA/CDER/OGD
- Roy Gulick, Weill Cornell Medical College
- Lanny Cross, Independent Consultant
- Jen Kates, Kaiser Family Foundation
Status:
The meeting took place Monday, March 31, 2014 in Washington, DC at UCDC Washington Center.
The Steering Committee for this project includes:
| John Bartlett, MD |
Johns Hopkins School of Medicine |
| Robert Besaw, MPH |
Forum for Collaborative HIV Research |
| Victoria Cargill, MD, MSCE |
Office of AIDS Research, National Institutes of Health |
| Jerome Ernst, MD |
ACRIA |
| David Evans | Project Inform |
| Tim Horn | Treatment Action Group |
| Veronica Miller, PhD | Forum for Collaborative HIV Research |
| Daniel Tietz, RN, JD | ACRIA |
| Rochelle Walensky, MD, MPH | Harvard Medical School; Mass Gen and B&W Hospitals |
| Andrea Weddle, MSW | HIV Medicine Association |
Special funding for this project has been provided by:
For questions or additional information, please contact Rob Besaw,
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
